One major finding of the present study is that leonurine decreases neurological deficit scores as well as infarct volume postischemic stroke, triggers antioxidant responses, and increases VEGF expression by activating the Nrf‐2 pathway. This evidence concerns the gene VEGFA and stroke disorder.